[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"asymptomatic-atrial-fibrillation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:asymptomatic-atrial-fibrillation":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100597464","subclinical-atrial-fibrillation-home-monitoring-in-hypertensive-patients-100597464",false,"NCT07058831","Subclinical Atrial Fibrillation Home Monitoring in Hypertensive Patients","Home Monitoring for the Detection of Subclinical Atrial Fibrillation in Hypertensive Patients at Moderate to High Risk of Developing Arrhythmia. BP\u002FAF MODE Study.","Inclusion Criteria:\n\n* 1\\. Hypertensive patients of both sexes over 75 years of age. 2. Hypertensive patients between 65 and 75 years of age are associated with one of the following risk factors:\n\n  1. Obesity\n  2. Type 2 diabetes\n  3. Obstructive sleep apnea syndrome\n  4. Electrocardiogram showing left ventricular hypertrophy.\n  5. Left ventricular hypertrophy on echocardiogram.\n  6. Left atrial dilation.\n  7. Coronary artery disease\n  8. Chronic kidney disease\n  9. Heart failure with ejection fraction \\> 50%\n  10. Alcohol intake\n  11. Frequent supraventricular ectopic beats\n\nExclusion Criteria:\n\n* 1\\. History of any type of atrial fibrillation. 2. Receiving pharmacological treatments with potential impact on heart rhythm. 3. History of potentially malignant ventricular arrhythmias. 4. Uncontrolled hypothyroidism or hyperthyroidism. 5. Significant chronic obstructive pulmonary disease.",true,"ALL","65 Years",{"count":20,"type":21},499,"ESTIMATED","7 Days","OBSERVATIONAL","Atrial fibrillation is a highly prevalent and incidental arrhythmia, often asymptomatic, and frequently detected incidentally or in association with a stroke. Subclinical atrial fibrillation increases cardioembolic risk, highlighting the need for timely diagnosis.\n\nNew wireless devices capable of recording heart rhythm, combined with innovative artificial intelligence tools, could be useful in the prediction and detection of this arrhythmia.\n\nObjective: to determine the usefulness of home blood pressure and heart rhythm monitoring strategy in the detection of subclinical atrial fibrillation.\n\nMethods: observational, cohort, prospective, multicenter study involving 25 researchers from six Latin American countries. Home blood pressure monitoring and single-lead electrocardiogram recording were performed in a population at moderate to high risk of developing atrial fibrillation. A minimum of twenty 30-second electrocardiographic and blood pressure recordings over 7 days using an Omron Complete Hem-7530 T ECG device will be uploaded from a mobile phone app and then sent to a database for analysis.\n\nConclusions: the results of this study can provide a simple and accessible home monitoring system for detecting subclinical atrial fibrillation and for optimizing the predictive capacity of arrhythmia risk scores through deep learning.",[26],"Asymptomatic Atrial Fibrillation",[28,29,30,31],"hypertension","atrial fibrillation","home monitoring","artificial intelligence","RECRUITING","2025-07-09",{"date":35,"type":36},"2025-07-10","ACTUAL",{"date":38,"type":36},"2025-03-01",{"date":40,"type":21},"2025-12-30",{"name":42,"class":43},"Cardiovascular Research Center Rosario British Sanatorium","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":17,"minAge":52,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":55,"phases":56,"briefSummary":58,"conditions":59,"keywords":66,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":44},"100571781","diagnosis-of-atrial-fibrillation-in-postoperative-thoracic-surgery-using-a-smartwatch-100571781","NCT06724718","Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch","THO-FA-WATCH","Inclusion Criteria:\n\n* Adults (\\>18 years old).\n* Patients undergoing major thoracic surgery with one-lung ventilation within the past 48 hours.\n* Scheduled pneumonectomy or lobectomy.\n* Admission to a conventional surgical unit postoperatively.\n* Ability to perform single-lead ECG using a smartwatch.\n* Coverage under a social security system.\n* Signed informed consent\n\nExclusion Criteria:\n\n* History of atrial fibrillation.\n* Requirement for telemetry for AV block or tachyarrhythmias (\\>140 bpm).\n* Dependency on a pacemaker.\n* Participation in another interventional clinical trial affecting POAF incidence.\n* Mediastinal, pleural, or chest wall surgery.\n* Reoperations or surgeries performed more than 48 hours prior.\n* Pregnant women.\n* Patients under guardians or similar legal protection.","18 Years",{"count":54,"type":21},302,"INTERVENTIONAL",[57],"NA","Postoperative atrial fibrillation (POAF) occurs in approximately 20% of patients following thoracic surgery. Early diagnosis is essential to prevent complications such as heart failure, stroke, myocardial infarction, and increased mortality. Smartwatches equipped with single-lead ECG capabilities and algorithms to detect asymptomatic atrial fibrillation (AF) offer a potential solution. This study aims to evaluate the effectiveness of smartwatches in detecting POAF compared to standard care.",[60,61,62,63,64,26,65],"Postoperative Atrial Fibrillation","Thoracic Surgery","Smartwatches","Rhythm Monitoring","Cardiovascular Prognosis","Randomized Trial",[67,68,69,70,71,72,73],"Postoperative atrial fibrillation","thoracic surgery","smartwatches","rhythm monitoring","cardiovascular prognosis","asymptomatic atrial fibrillation","randomized trial","2025-06-11",{"date":76,"type":36},"2025-06-12",{"date":78,"type":36},"2025-06-01",{"date":80,"type":21},"2027-12",{"name":82,"class":43},"Centre Hospitalier Universitaire, Amiens"]